United Kingdom · Who invested in Greywolf Therapeutics?
Greywolf Therapeutics's investors include Canaan, Andera Partners, Earlybird Venture Capital and Oxford Science Enterprises.
201920202021202220232024
$14MSeries A$4.9MRound$39MRound$36MSeries B$50MSeries B
United Kingdom · Series B startup
Who invested in Greywolf Therapeutics
Funding summaryUpdated 26 Oct 2026
$144Mraised across 5 rounds since 2019, from 5 sources
$14MSeries A$4.9MRound$39MRound$36MSeries B$50MSeries B
- Latest round
- Series B, $50MMay 2024
- Step-upi
- 1.4×
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $14M Feb 2019
- Biggest round
- $50M Series B · May 2024
- Usual gap between rounds
- 16 months the median of 4
The rounds
- May 2024Series B$50M2 new2 returning
Source recorded
- Jan 2023Series B$36M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Dec 2021Round$39M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Oct 2021Round$4.9M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Feb 2019
Funding filed with regulators
Greywolf Therapeutics filed 3 raises, $80M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jan 2023$36MUK share allotment
- Dec 2021$39MUK share allotment
- Oct 2021$4.9MUK share allotment
Founders and team
From Greywolf Therapeutics's own website: 2 founders, 7 on the team.
Peter JoyceChief Executive Officer & Co-founder
Tom McCarthyNon-Executive Director & Co-founder
- Andy PageChief Business Officer
- Paul StainerChief Operating Officer
- Tom LillieChief Medical Officer
- James DodsonHead of People
- Jo HumeHead of Finance
- Dr Edwin MosesChair
- Thierry HercendIndustry Expert Director
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2019Round2021Round2021Series B2023Series B2024
Canaan
Andera Partners
Earlybird Venture Capital
Oxford Science Enterprises
CanaanAndera PartnersEarlybird Venture CapitalOxford Science EnterprisesEveryone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Greywolf Therapeutics
How much has Greywolf Therapeutics raised?
Greywolf Therapeutics has raised $144M across 5 rounds since 2019.
When did Greywolf Therapeutics last raise?
Greywolf Therapeutics's most recent round was a Series B of $50M in May 2024.
What was Greywolf Therapeutics's biggest round?
Its most recent round, $50M in May 2024, is also its largest on record.
Who backed Greywolf Therapeutics first?
Greywolf Therapeutics's first round on record, in Feb 2019, was backed by Canaan and Andera Partners.
What stage is Greywolf Therapeutics at?
Greywolf Therapeutics's latest named round is a Series B, in May 2024.
Where is Greywolf Therapeutics based?
Greywolf Therapeutics is based in the United Kingdom.
Companies like Greywolf Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.